Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00656305 · ClinicalTrials.gov registry record · NA
ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain
A NA study, sponsored by InSightec.
- Completed
- Registry status
- NA
- Development phase
- 147
- Enrollment target
NCT00656305 is a NA study that has completed, run by InSightec. The registered enrollment target is 147 participants.
The verdict
NCT00656305, a NA study, has completed, sponsored by InSightec.
- COMPLETED
- Registry status
- NA
- Development phase
- 147 participants
- Enrollment target
Study Summary
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone and Multiple Myeloma Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Interventions
- DEVICE Sham
- DEVICE ExAblate MRfFUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00656305
The ClinicalTrials.gov registry entry for NCT00656305 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT00656305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00656305 about?
NCT00656305 is a clinical study titled "ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain". A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone and Multiple Myeloma Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
What is the current status of trial NCT00656305?
This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2008-03. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00656305?
The interventions under investigation include: Sham (DEVICE), ExAblate MRfFUS (DEVICE).
Who is sponsoring clinical trial NCT00656305?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.